Chris DelOrefice | VP, IR |
Joe Wolk | Executive Vice President, Chief Financial Officer |
Jennifer Taubert | Executive Vice President and Worldwide Chairman, Pharmaceuticals |
Ashley McEvoy | Executive Vice President and Worldwide Chairman, Medical Devices |
Thibaut Mongon | Executive Vice President and Worldwide Chairman, Consumer Health |
Mathai Mammen | Global Head of Janssen Research & Development |
David Lewis | Morgan Stanley |
Chris Schott | JPMorgan |
Larry Biegelsen | Wells Fargo |
Josh Jennings | Cowen & Co |
Danielle Antalffy | SVB Leerink |
Terence Flynn | Goldman Sachs |
Louise Chen | Cantor Fitzgerald |
Good morning, and welcome to Johnson & Johnson's Third Quarter 2020 Earnings Conference Call. All participants will be in listen-only mode until the question-and-answer session of the conference. This call is being recorded. [Operator Instructions] I would now like to turn the conference call over to Johnson & Johnson.
You may begin.